New startup ideas · Health and bio · Healthcare and bio
startup idea
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
- Infrastructure and APIs
- Enterprise
- $100B+ market
- Creates a new category
- US first
5/5
venture judge
36
similar startups, last 2 years (130 all-time)
97%
of 4 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
71
Idea Score, 0-100 · raw 43.5 x 1.64
Crowded
competition: more crowded than 95% of ideas · headwind x0.53
+4.8
government priorities, secondary (171 matching grants)
Trend
73
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)49
- Rounds announced 2025+ in the sector68
- Sector direction (live batch)100
- 2026 trend analyst75
Demand
68
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain75
100x potential
80
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge100
- Market size axis100
- Moat axis80
- Neighbours still alive74
- Technologist judge25
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were consented, medical-records, rail, clinic, ai-native, care, pull, patient.
The idea in full
- What
- An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse. Customers integrate one REST endpoint instead of negotiating with hundreds of health systems; ChartRail's regulatory standing does the work, not novel ML. Pricing is per record retrieved, so revenue starts with the first customer's first patient.
- Why now
- The YC S26 and X26 batches are stacked with AI-native care delivery - Standard Medical's AI primary care clinic, Clara's AI primary care doctor, Radley's AI-native radiology practice - and Hubble's pitch is literally 'Retrieve records other APIs can't', which shows the rail is missing and buyers already feel it.
- Wedge: first customer and entry point
- Founder-led sales to the ten newest AI-clinic startups, who all need longitudinal records before their first patient visit and have no compliance team to build access themselves.
- Path to 100x
- US healthcare data exchange and the administration around it is a $100B+ spend, and a new category - the consent-and-records rail for autonomous care - gets defined by whoever the first hundred AI clinics standardize on. The qualification is slow and political to obtain, so incumbency in the license compounds while integration switching costs lock customers in.
- Ceiling
- EHR vendors open equivalent APIs natively and the rail becomes a feature of the systems it was routing around.
- Closest real companies, as the generator saw them
- Hubble retrieves records but sells retrieval as a capability; ChartRail's difference is making regulatory qualification itself the product, so access rights and consent standing, not scraping skill, are what customers buy. Standard Medical and Clara are buyers, not rivals.
- Main risk
- The exchange frameworks tighten rules against third-party AI use cases and ChartRail's permitted-purpose standing evaporates overnight.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
5/5
Capital-light, revenue from the first record, and a slow political qualification that compounds while the first hundred AI clinics standardize on it.
Bootstrapper
3/5
Per-record revenue from day one on software margins, but the exchange-framework qualification is slow and political and can be revoked.
Operator
4/5
AI clinics need longitudinal records before their first visit, pay per record from day one, and have no compliance team to build access themselves.
Technologist
2/5
The card states regulatory standing, not novel ML, is the product, and EHR vendors shipping native APIs erases it.
Risk
2/5
The entire product is one permitted-purpose standing in a national exchange framework the card admits could evaporate overnight, sold to ten new AI clinics.
trends
4/5
Its buyers - AI-native clinics like Standard Medical, Clara, Radley - only exist since the 2025-2026 batches, and slow regulatory qualification rewards moving now.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (consented, medical-records, rail, clinic, ai-native, care, pull, patient): 130 all-time, 36 from the last two years. Same matching as Idea Check.
AI-native patient engagement
AI-native platform for Life-Sciences Documentation
Logistics infrastructure to modernize healthcare operations
The operations stack for biologic infusion clinics
AI-native operating system for behavioral health clinics.
Software to launch and integrate genetics into clinical care
Autonomous medical care
Remote patient monitoring for musculoskeletal health
Levisonics is developing a drop-of-blood, point-of-care coagulation analyzer that delivers in a single test the comprehensive clotting insights that today require multiple separate lab and point-of-care tests.
Financial infrastructure for family caregiving
Clinically Integrated Group for Mental Health
A primary care clinic where AI earns clinical autonomy
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1127
startup-relevant grants in Healthcare and bio
$590M
awarded in the sector, tracked
130
opportunities open now in the sector
NIH / NIA · SBIR phase II · $506K · posted 2025-09-22
- Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorderawardhigh relevance
NIH / NIDA · SBIR phase I · $307K · posted 2025-09-01
- I-Corps: Translation potential of a conversational Artificial Intelligence (AI) system for post-discharge patient follow-upawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-21
- I-Corps: Translation Potential of a Biomechanics-Driven Optimization of Dental X-Ray Bite Blocks for Enhanced Patient Comfortawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-20
- I-Corps: Translation potential of a wound care technology that combines hydrogel-like biomaterial with specific protein binders to accelerate healing and tissue repairawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-20
- I-Corps: Translation Potential of Wearable Biomechanics Assessment for Mobility Evaluationawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-20
- I-Corps: Translation potential of a clinical decision support system for evidence-based reasoning for disease management and preventionawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-17
National Science Foundation · I-Corps · $50K · posted 2026-08-17
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 130 → 118 → 216 → 173 → 71 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 21 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Enterprise
- Business model
- Infrastructure and APIs
- Path to 100x
- Creates a new category
- Market size
- $100B+ market
- Capital intensity
- Capital-light (software margins)
- Speed to revenue
- Revenue within a year
- Technical depth
- Integrations, no-code
- Go-to-market
- Founder-led sales
- Moat
- License or regulatory moat
- Geography
- US first
- Regulation
- Some regulation
- Vibe
- Boring business
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
Claimsmith
The agent platform where healthcare's back office gets rebuilt by everyone but us.
Claimsmith is a no-code platform where hospitals, billing companies, and health IT vendors build and run AI agents for administrative work: eligibility checks, prior authorization, claims appeals, and records chasing.
Fictional company written 2026-08-26 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.